Chinese expert consensus on the diagnosis and treatment of peritoneal metastasis of gastric cancer (2023 edition).
10.3760/cma.j.cn441530-20230608-00196
- Collective Name:Gastric Cancer Committee of China Anti Cancer Association
- Publication Type:Journal Article
- MeSH:
Humans;
Peritoneum/pathology*;
Peritoneal Neoplasms/therapy*;
Stomach Neoplasms/pathology*;
Consensus;
East Asian People;
Quality of Life;
China
- From:
Chinese Journal of Gastrointestinal Surgery
2023;26(8):717-728
- CountryChina
- Language:Chinese
-
Abstract:
China is a country with a high incidence of gastric cancer, and the majority of patients are in the advanced stage. The peritoneum is the most common site of metastasis and recurrence in advanced gastric cancer. Attention to the standardized diagnosis and treatment of peritoneal metastases of gastric cancer is expected to significantly improve the prognosis and quality of life of some patients. Based on evidence-based medicine and the internationally accepted Delphi method, this consensus revises the Chinese expert consensus on the prevention and treatment of peritoneal metastasis of gastric cancer (2017 edition), reaches a preliminary consensus on the definition, classification, risk factors, diagnosis and prediction, grade assessment, prevention, treatment and management of complications of peritoneal metastasis of gastric cancer, and provides guidance for clinical work.
